Day: September 4, 2024

U.S. Physicians Overwhelmingly Support Current FDA Data Standards, Switching Studies for Interchangeable Biosimilars; Oppose Pharmacy Substitution of Non-Interchangeable Biosimilars

ARLINGTON, VA / ACCESSWIRE / September 4, 2024 / U.S. physicians overwhelmingly support maintaining the Food and Drug Administration's (FDA's)...

Xevant and RxPreferred Expand Partnership, Including Strategic Co-Investments to Deliver Innovative, Transparent, and Technology-Driven Pharmacy Benefits Solutions

Disrupting Traditional Pharmacy Benefits Models to Drive Down Healthcare Costs SALT LAKE CITY & NASHVILLE, Tenn., Sept. 4, 2024 /PRNewswire/...

Carterra unveils its most sensitive biosensor platform; Carterra Ultra™ ushers in a new frontier in fragment and small molecule drug discovery

The new instrument enables high-throughput small and large molecule characterization in traditional and AI-driven workflows   SALT LAKE CITY, Sept. 4,...

error: Content is protected !!